Advertisement
U.S. markets closed

Arcadia Biosciences, Inc. (RKDA)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
2.4700-0.0600 (-2.37%)
At close: 04:00PM EDT
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
Total Revenue
7,442
9,956
6,780
8,034
Cost of Revenue
7,231
9,802
8,708
5,199
Gross Profit
211
154
-1,928
2,835
Operating Expense
19,281
19,557
26,827
24,427
Operating Income
-19,070
-19,403
-28,755
-21,592
Net Non Operating Interest Income Expense
704
289
-20
-47
Other Income Expense
-126
3,516
12,643
15,489
Pretax Income
-18,492
-15,598
-16,132
-6,150
Tax Provision
14
14
2
-124
Net Income Common Stockholders
-15,372
-15,376
-14,660
-4,655
Diluted NI Available to Com Stockholders
-15,372
-15,376
-14,660
-4,655
Basic EPS
-15.59
-25.65
-27.56
-18.80
Diluted EPS
-15.59
-25.65
-27.56
-18.80
Basic Average Shares
1,065
599.389
532.016
248.975
Diluted Average Shares
1,065
599.389
532.016
248.975
Total Operating Income as Reported
-20,040
-18,815
-35,526
-12,778
Total Expenses
26,512
29,359
35,535
29,626
Net Income from Continuing & Discontinued Operation
-15,372
-15,376
-14,660
-4,655
Normalized Income
-18,613
-18,376
-17,068
-19,124
Interest Expense
-
-
20
47
Net Interest Income
704
289
-20
-47
EBIT
-19,070
-19,403
-28,755
-6,103
EBITDA
-18,757
-18,924
-27,710
-5,441
Reconciled Cost of Revenue
7,231
9,802
8,708
5,199
Reconciled Depreciation
313
479
1,045
662
Net Income from Continuing Operation Net Minority Interest
-18,417
-15,376
-14,660
-4,655
Total Unusual Items Excluding Goodwill
248
3,797
3,298
14,749
Total Unusual Items
248
3,797
3,298
14,749
Normalized EBITDA
-19,005
-22,721
-31,008
-20,190
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
52.08
797.37
890.46
280.231